HMS
PDLI

Hanseatic Management Services’s PDL BioPharma, Inc. PDLI Stock Holding History

Hanseatic Management Services’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,115
Closed -$11K – 424
2014
Q2 		$11K Buy
+1,115
New +$9.94K 0.01% 236

Other funds holding PDLI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hanseatic Management Services's PDLI Position: Q3 2014 in Review

Hanseatic Management Services sold out of PDL BioPharma, Inc. (PDLI) in Q3 2014, closing a stake of 1,115 shares — an estimated $11K sold.

Hanseatic Management Services first reported a position in PDLI in Q2 2014 and held it in 1 quarter. The position peaked at $11K in Q2 2014. 231 funds tracked by Wall St. Rank hold PDLI as of Q3 2014.

  • Hanseatic Management Services reported no remaining PDL BioPharma, Inc. position as of Q3 2014 after selling out during the quarter.
  • Hanseatic Management Services sold 1,115 PDL BioPharma, Inc. shares in Q3 2014, an estimated $11K.
  • Hanseatic Management Services first reported a position in PDL BioPharma, Inc. in Q2 2014 and held it in 1 quarter.
  • Hanseatic Management Services's PDL BioPharma, Inc. position peaked at $11K in Q2 2014.
  • 231 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2014.

Based on Hanseatic Management Services's 13F filing for Q3 2014, filed 30 Oct 2014.